Lixte Biotechnology Holdings Stock Probability of Future Stock Price Finishing Over 7.12

LIXT Stock  USD 3.52  1.26  55.75%   
Lixte Biotechnology's future price is the expected price of Lixte Biotechnology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Lixte Biotechnology Holdings performance during a given time horizon utilizing its historical volatility. Check out Lixte Biotechnology Backtesting, Lixte Biotechnology Valuation, Lixte Biotechnology Correlation, Lixte Biotechnology Hype Analysis, Lixte Biotechnology Volatility, Lixte Biotechnology History as well as Lixte Biotechnology Performance.
  
At this time, Lixte Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.03 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (1.10) in 2024. Please specify Lixte Biotechnology's target price for which you would like Lixte Biotechnology odds to be computed.

Lixte Biotechnology Target Price Odds to finish over 7.12

The tendency of Lixte Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 7.12  or more in 90 days
 3.52 90 days 7.12 
close to zero percent
Based on a normal probability distribution, the odds of Lixte Biotechnology to move over $ 7.12  or more in 90 days from now is close to zero percent (This Lixte Biotechnology Holdings probability density function shows the probability of Lixte Stock to fall within a particular range of prices over 90 days) . Probability of Lixte Biotechnology price to stay between its current price of $ 3.52  and $ 7.12  at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.36 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Lixte Biotechnology will likely underperform. Additionally Lixte Biotechnology Holdings has an alpha of 0.4994, implying that it can generate a 0.5 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Lixte Biotechnology Price Density   
       Price  

Predictive Modules for Lixte Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lixte Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.183.6813.27
Details
Intrinsic
Valuation
LowRealHigh
0.132.6112.20
Details
Naive
Forecast
LowNextHigh
0.073.6113.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.492.683.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lixte Biotechnology. Your research has to be compared to or analyzed against Lixte Biotechnology's peers to derive any actionable benefits. When done correctly, Lixte Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lixte Biotechnology.

Lixte Biotechnology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Lixte Biotechnology is not an exception. The market had few large corrections towards the Lixte Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lixte Biotechnology Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lixte Biotechnology within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.50
β
Beta against NYSE Composite4.36
σ
Overall volatility
0.28
Ir
Information ratio 0.1

Lixte Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lixte Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lixte Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Lixte Biotechnology is way too risky over 90 days horizon
Lixte Biotechnology appears to be risky and price may revert if volatility continues
Lixte Biotechnology has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (5.09 M) with profit before overhead, payroll, taxes, and interest of 0.
Lixte Biotechnology Holdings currently holds about 7.74 M in cash with (4.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Lixte Biotechnology has a poor financial position based on the latest SEC disclosures
Roughly 23.0% of the company outstanding shares are owned by corporate insiders
Latest headline from benzinga.com: Why Lixte Biotechnology Stock Is Soaring

Lixte Biotechnology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lixte Stock often depends not only on the future outlook of the current and potential Lixte Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lixte Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.9 M
Cash And Short Term Investments4.2 M

Lixte Biotechnology Technical Analysis

Lixte Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Lixte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lixte Biotechnology Holdings. In general, you should focus on analyzing Lixte Stock price patterns and their correlations with different microeconomic environments and drivers.

Lixte Biotechnology Predictive Forecast Models

Lixte Biotechnology's time-series forecasting models is one of many Lixte Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lixte Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Lixte Biotechnology

Checking the ongoing alerts about Lixte Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lixte Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Lixte Biotechnology is way too risky over 90 days horizon
Lixte Biotechnology appears to be risky and price may revert if volatility continues
Lixte Biotechnology has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (5.09 M) with profit before overhead, payroll, taxes, and interest of 0.
Lixte Biotechnology Holdings currently holds about 7.74 M in cash with (4.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Lixte Biotechnology has a poor financial position based on the latest SEC disclosures
Roughly 23.0% of the company outstanding shares are owned by corporate insiders
Latest headline from benzinga.com: Why Lixte Biotechnology Stock Is Soaring
When determining whether Lixte Biotechnology is a strong investment it is important to analyze Lixte Biotechnology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lixte Biotechnology's future performance. For an informed investment choice regarding Lixte Stock, refer to the following important reports:

Complementary Tools for Lixte Stock analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Lixte Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lixte Biotechnology. If investors know Lixte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lixte Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.66)
Return On Assets
(0.64)
Return On Equity
(1.11)
The market value of Lixte Biotechnology is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotechnology's market value can be influenced by many factors that don't directly affect Lixte Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lixte Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.